Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
989
datasets available to search
ShareScore release 0.9.0
Dataset results
989 results for “Myelodysplastic syndrome”
Lenalidomide Versus Placebo in Myelodysplastic Syndromes With a Deletion 5q[31] Abnormality
ClinicalTrials.gov study NCT00179621. IPD Sharing: Not stated. Countries: 9. Publications: 4.
SGI-110 in Participants With Myelodysplastic Syndromes (MDS) or Acute Myelogenous Leukemia (AML)
ClinicalTrials.gov study NCT01261312. IPD Sharing: Not stated. Countries: 2. Publications: 3.
A Study of Decitabine Given to Adults With Advanced-Stage Myelodysplastic Syndromes
ClinicalTrials.gov study NCT00260065. IPD Sharing: Not stated. Countries: 2. Publications: 2.
A Study of Decitabine Given Subcutaneously to Adults With Low or Intermediate-1 Risk Myelodysplastic Syndromes (MDS)
ClinicalTrials.gov study NCT00619099. IPD Sharing: Not stated. Countries: 1. Publications: 1.
A Telehealth Advance Care Planning Intervention for Older Patients With Acute Myeloid Leukemia and Myelodysplastic Syndrome
ClinicalTrials.gov study NCT04745676. IPD Sharing: YES. Countries: 1. Publications: 3.
Study of Three Different Schedules of Low-Dose Decitabine in Myelodysplastic Syndrome (MDS)
ClinicalTrials.gov study NCT00067808. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Study of Azacitidine in Adult Taiwanese Subjects With Higher-Risk Myelodysplastic Syndromes (MDS)
ClinicalTrials.gov study NCT01201811. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Controlled Study of Post-transplant Azacitidine for Prevention of Acute Myelogenous Leukemia and Myelodysplastic Syndrome Relapse (VZ-AML-PI-0129)
ClinicalTrials.gov study NCT00887068. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Lirilumab and Nivolumab With 5-Azacitidine in Patients With Myelodysplastic Syndromes (MDS)
ClinicalTrials.gov study NCT02599649. IPD Sharing: Not stated. Countries: 1. Publications: 1.
A Study of JNJ-30979754 (Decitabine) in Patients With Myelodysplastic Syndrome
ClinicalTrials.gov study NCT00796003. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Lenalidomide With or Without Epoetin Alfa in Treating Patients With Myelodysplastic Syndrome and Anemia
ClinicalTrials.gov study NCT00843882. IPD Sharing: Not stated. Countries: 1. Publications: 1.
A Study of Galunisertib in Participants With Myelodysplastic Syndromes
ClinicalTrials.gov study NCT02008318. IPD Sharing: YES. Countries: 3. Publications: 1.
Phase 1/2 Study of the ERK1/2 Inhibitor BVD-523 in Patients With Acute Myelogenous Leukemia or Myelodysplastic Syndromes
ClinicalTrials.gov study NCT02296242. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Clofarabine vs Clofarabine in Plus With Low-Dose Ara-C in Previously Untreated Patients With Acute Myeloid Leukemia (AML) and High-Risk Myelodysplastic Syndromes (MDS).
ClinicalTrials.gov study NCT00088218. IPD Sharing: Not stated. Countries: 1. Publications: 1.
5-Azacytidine With Lenalidomide in Patients With High Risk Myelodysplastic Syndrome (MDS) and Acute Myelogenous Leukemia (AML)
ClinicalTrials.gov study NCT01038635. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Sorafenib Plus 5-Azacitidine Initial Therapy of Patients With Acute Myeloid Leukemia (AML) and High Risk Myelodysplastic Syndrome (MS) With FLT3-ITD Mutation
ClinicalTrials.gov study NCT02196857. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Testing the Safety and Efficacy of the Combination of the Antibody Pembrolizumab and Entinostat in Patients With Myelodysplastic Syndrome Who Are Not Responding to Hypomethylating Agents
ClinicalTrials.gov study NCT02936752. IPD Sharing: Not stated. Countries: 1. Publications: 1.
A Study to Compare the Efficacy and Safety of Luspatercept (ACE-536) Versus Epoetin Alfa for the Treatment of Anemia Due to IPSS-R Very Low, Low, or Intermediate Risk Myelodysplastic Syndromes (MDS) P
ClinicalTrials.gov study NCT03682536. IPD Sharing: Not stated. Countries: 26. Publications: 4.
Sirolimus and Azacitidine in Treating Patients With High Risk Myelodysplastic Syndrome or Acute Myeloid Leukemia That is Recurrent or Not Eligible for Intensive Chemotherapy
ClinicalTrials.gov study NCT01869114. IPD Sharing: Not stated. Countries: 1. Publications: 39.
Study of Vosaroxin and Decitabine in Older Patients With Acute Myeloid Leukemia and High-risk Myelodysplastic Syndrome
ClinicalTrials.gov study NCT01893320. IPD Sharing: Not stated. Countries: 1. Publications: 1.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.